Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2012
12/26/2012EP2536693A1 Substituted 2-imidazolidones and analogs
12/26/2012EP2536689A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
12/26/2012EP2536283A1 Phenyl-heteroaryl derivatives and methods of use thereof
12/26/2012CN1922193B Chemical process
12/26/2012CN1826333B Diamine derivatives
12/26/2012CN102844313A Compositions and methods for enhancing proteasome activity
12/26/2012CN102844305A Antibacterial isoquinolin-3-ylurea derivatives
12/26/2012CN102844304A Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide
12/26/2012CN102844299A Pesticidal arylpyrrolidines
12/26/2012CN102838590A Amino quinazoline derivative and application thereof in preparation of antineoplastic drugs
12/26/2012CN102838588A Oral thrombin inhibitors, preparation methods and medical uses thereof
12/26/2012CN102838587A Peptide bond containing cis nitenpyram analogue, and preparation and application thereof
12/26/2012CN102838586A Method for preparing lenalidomide
12/26/2012CN102838539A Quinolinylenamide derivative and its application in preparation of anti-malignant tumor drugs
12/26/2012CN102838532A Novel compounds for a treatment of diseases associated with amyloid or amyloid-like proteins
12/26/2012CN102153502B Carbazole derivative and light-emitting element and light-emitting apparatus using carbazole derivative
12/26/2012CN101812021B Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same
12/26/2012CN101730703B Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof
12/26/2012CN101466678B Substituted 3-cyanopyridines as protein kinase inhibitors
12/26/2012CN101258143B 苄基哌嗪衍生物及其医学用途 Benzyl piperazine derivatives and their medical use
12/25/2012USRE43878 Amidophenoxyindazoles useful as inhibitors of c-Met
12/25/2012US8338614 e.g. 2-[5-(5-methyl-1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazol-2-yl]-1-phenylpropan-2-amine; neurodegenerative diseases; preventing the formation of insoluble amyloid beta and arresting the production of amyloid beta
12/25/2012US8338609 Ligand, metal complex compound containing the same, and method for producing the same, and method for producing molecular device
12/25/2012US8338607 Cyclic amine compounds and agents for pest control
12/25/2012US8338594 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
12/25/2012US8338590 Substituted oxindole derivatives and medicaments containing the same
12/25/2012US8338462 1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
12/25/2012US8338461 1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
12/25/2012US8338455 Pyridines or pyrimidines having 4-(hydrogenated 1-pyridyl- or hydrogenated 1-isoquinolyl rings, e.g., N-(4-chlorophenyl)-2-(pyridin-4-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
12/25/2012US8338440 Inhibitors of IAP
12/25/2012US8338434 Inhibitors of Akt activity
12/25/2012US8338433 Tyrosine kinase inhibitors as anti-kinetoplastid agents
12/25/2012US8338419 N-thio-anthranilamid compounds and their use as pesticides
12/25/2012US8338418 Dual-acting antihypertensive agents
12/25/2012US8338417 Compounds and compositions as c-kit and PDGFR kinase inhibitors
12/25/2012US8338416 Indole derivatives as inhibitors of histone deacetylase
12/25/2012US8338412 Inhibitors of P38
12/25/2012US8338408 Tetracyclic compounds
12/25/2012US8338406 Benzodiazepine compound and pharmaceutical composition
12/20/2012WO2012174362A1 Pyrazole derivatives as cannabinoid receptor 1 antagonists
12/20/2012WO2012174312A2 Benzimidazole derivatives as antiviral agents
12/20/2012WO2012174164A2 Agonists of gpr131 and uses thereof
12/20/2012WO2012174082A1 Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
12/20/2012WO2012173521A2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon
12/20/2012WO2012173219A1 Novel biaryl ether derivative
12/20/2012WO2012173174A1 Azaspiroalkane compound
12/20/2012WO2012173073A1 Light emitting element material and light emitting element
12/20/2012WO2012173011A1 Organic electric-field light-emitting element, light-emitting material for organic electric-field light-emitting element, and light-emitting device, display device, and illumination device using same element
12/20/2012WO2012171863A1 New selective ccr2 antagonists
12/20/2012WO2012171487A1 Aryloxy quinolines derivatives and the treating use thereof
12/20/2012WO2012171479A1 Oxazolidinone compounds and their uses in preparation of antibiotics
12/20/2012WO2012171337A1 Therapeutically active compositions and their methods of use
12/20/2012WO2012148090A3 Production of diamine having a novel structure containing a terpyridine or phenanthroline functional group and a use therefor
12/20/2012WO2011109680A3 Process for the preparation of 2-(cyclohexylmethyl)-n-{2- [(2s)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4- tetrahydroisoquinoline-7-sulfonamide
12/20/2012US20120323006 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
12/20/2012US20120323003 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
12/20/2012US20120322833 Pesticidal Arylpyrrolidines
12/20/2012US20120322831 Compositions for reducing ab 42 production and their use in treating alzheimer's disease (ad)
12/20/2012US20120322830 Cyclourea Compounds as Calcium Channel Blockers
12/20/2012US20120322826 5-ht4 receptor agonists for the treatment of dementia
12/20/2012US20120322825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
12/20/2012US20120322820 Methods to inhibit tumor cell growth by using proton pump inhibitors
12/20/2012US20120322808 Alpha 4 Beta 2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
12/20/2012US20120322804 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
12/20/2012US20120322803 Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
12/20/2012US20120322802 Novel 2, 4-pyrimidine derivatives and use thereof
12/20/2012US20120322801 Heterocyclic amides as rock inhibitors
12/20/2012US20120322800 Sepiapterin Reductase Inhibitors For The Treatment of Pain
12/20/2012US20120322795 Biarylamide inhibitors of leukotriene production
12/20/2012US20120322785 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
12/20/2012US20120322772 Substituted imidazopyrimidines and triazolopyrimidines
12/20/2012US20120321563 Carbonic Anhydrase Targeting Agents and Methods of Using Same
12/20/2012US20120319099 Material for organic electroluminescence devices and organic electroluminescence device using the material
12/20/2012US20120319098 Substituted pyridyl compound and organic electroluminescent element
12/20/2012US20120319087 Heterocyclic compound and organic light-emitting device containing same
12/20/2012US20120319052 Compounds for electronic devices
12/20/2012DE19882402B3 Blockoligomere, enthaltend 1-Kohlenwasserstoffoxy-2,2,6,6-tetramethyl-4-piperidyl-Gruppen als Stabilisatoren für organische Materialien Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
12/20/2012DE102012202012A1 Heterocyclische Verbindung und diese enthaltende organische lichtemittierende Anzeige Heterocyclic compound, and this organic light emitting display containing
12/20/2012CA2850137A1 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon
12/20/2012CA2839675A1 Therapeutically active compositions and their methods of use
12/20/2012CA2838741A1 Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-[5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
12/19/2012EP2535338A1 Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile
12/19/2012EP2535337A1 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide sulfate and its amorphous form
12/19/2012EP2535336A1 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
12/19/2012EP2535331A1 Condensed-Cyclic Compound and Organic Light-Emitting Diode Comprising the Same
12/19/2012EP2535329A2 Spiro-piperidine derivatives
12/19/2012EP2534144A1 Preparation process of the sodium salt of esomeprazole
12/19/2012EP2533782A1 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS
12/19/2012EP2533641A2 Hydrazine-substituted anthranilic acid derivatives
12/19/2012EP2533640A1 Processes of synthesizing dihydropyridophthalazinone derivatives
12/19/2012CN1926103B Sulphonylpyrroles as HDAC inhibitors
12/19/2012CN102834389A Dimeric iap inhibitors
12/19/2012CN102834388A Cgrp receptor antagonist
12/19/2012CN102834387A Phenylpyri(mi)dinylpyrazoles and their use as fungicides
12/19/2012CN102834382A Pyrazole derivatives as modulators of calcium release-activated calcium channel
12/19/2012CN102834380A Inhibitors of protein kinases
12/19/2012CN102827148A Hindered amine compound and preparation method thereof
12/19/2012CN102827147A Omeprazole sodium crystal compound and medicine composition containing omeprazole sodium crystal compound
12/19/2012CN102827146A Fluoroquinolone acetal ftivazide as well as preparation method and application thereof
12/19/2012CN102827145A Novel deuterated o-aminobenzamide compound, and preparation method and application thereof